Page last updated: 2024-11-03

primaquine and Infant, Small for Gestational Age

primaquine has been researched along with Infant, Small for Gestational Age in 1 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Infant, Small for Gestational Age: An infant having a birth weight lower than expected for its gestational age.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brummaier, T1
Gilder, ME1
Gornsawun, G1
Chu, CS1
Bancone, G1
Pimanpanarak, M1
Chotivanich, K1
Nosten, F1
McGready, R1

Other Studies

1 other study available for primaquine and Infant, Small for Gestational Age

ArticleYear
Vivax malaria in pregnancy and lactation: a long way to health equity.
    Malaria journal, 2020, Jan-22, Volume: 19, Issue:1

    Topics: Adolescent; Aminoquinolines; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Femal

2020